Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2018 16:30 ET | Source: Osmotica Holdings US LLC

Osmotica Pharmaceuticals to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

BRIDGEWATER, N.J., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that...
November 08, 2018 16:01 ET | Source: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Reports Third Quarter 2018 Results

BRIDGEWATER, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced...
November 05, 2018 07:00 ET | Source: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc to Discuss Third Quarter 2018 Financial Results on November 8, 2018

BRIDGEWATER, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the...
October 22, 2018 16:30 ET | Source: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Announces Closing of Initial Public Offering

BRIDGEWATER, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the closing of its initial public offering of...
October 17, 2018 21:15 ET | Source: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering

BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the pricing of its initial public offering of...
February 19, 2018 13:00 ET | Source: Osmotica Pharmaceutical US LLC

FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER™ (amantadine) extended-release tablets for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions in Adults

BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous...